Literature DB >> 30553900

Using a Deep Learning Algorithm and Integrated Gradients Explanation to Assist Grading for Diabetic Retinopathy.

Rory Sayres1, Ankur Taly1, Ehsan Rahimy2, Katy Blumer1, David Coz1, Naama Hammel1, Jonathan Krause1, Arunachalam Narayanaswamy1, Zahra Rastegar1, Derek Wu1, Shawn Xu3, Scott Barb4, Anthony Joseph5, Michael Shumski6, Jesse Smith7, Arjun B Sood8, Greg S Corrado1, Lily Peng9, Dale R Webster1.   

Abstract

PURPOSE: To understand the impact of deep learning diabetic retinopathy (DR) algorithms on physician readers in computer-assisted settings.
DESIGN: Evaluation of diagnostic technology. PARTICIPANTS: One thousand seven hundred ninety-six retinal fundus images from 1612 diabetic patients.
METHODS: Ten ophthalmologists (5 general ophthalmologists, 4 retina specialists, 1 retina fellow) read images for DR severity based on the International Clinical Diabetic Retinopathy disease severity scale in each of 3 conditions: unassisted, grades only, or grades plus heatmap. Grades-only assistance comprised a histogram of DR predictions (grades) from a trained deep-learning model. For grades plus heatmap, we additionally showed explanatory heatmaps. MAIN OUTCOME MEASURES: For each experiment arm, we computed sensitivity and specificity of each reader and the algorithm for different levels of DR severity against an adjudicated reference standard. We also measured accuracy (exact 5-class level agreement and Cohen's quadratically weighted κ), reader-reported confidence (5-point Likert scale), and grading time.
RESULTS: Readers graded more accurately with model assistance than without for the grades-only condition (P < 0.001). Grades plus heatmaps improved accuracy for patients with DR (P < 0.001), but reduced accuracy for patients without DR (P = 0.006). Both forms of assistance increased readers' sensitivity moderate-or-worse DR: unassisted: mean, 79.4% [95% confidence interval (CI), 72.3%-86.5%]; grades only: mean, 87.5% [95% CI, 85.1%-89.9%]; grades plus heatmap: mean, 88.7% [95% CI, 84.9%-92.5%] without a corresponding drop in specificity (unassisted: mean, 96.6% [95% CI, 95.9%-97.4%]; grades only: mean, 96.1% [95% CI, 95.5%-96.7%]; grades plus heatmap: mean, 95.5% [95% CI, 94.8%-96.1%]). Algorithmic assistance increased the accuracy of retina specialists above that of the unassisted reader or model alone; and increased grading confidence and grading time across all readers. For most cases, grades plus heatmap was only as effective as grades only. Over the course of the experiment, grading time decreased across all conditions, although most sharply for grades plus heatmap.
CONCLUSIONS: Deep learning algorithms can improve the accuracy of, and confidence in, DR diagnosis in an assisted read setting. They also may increase grading time, although these effects may be ameliorated with experience.
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30553900     DOI: 10.1016/j.ophtha.2018.11.016

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  49 in total

1.  Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application.

Authors:  Valentina Bellemo; Gilbert Lim; Tyler Hyungtaek Rim; Gavin S W Tan; Carol Y Cheung; SriniVas Sadda; Ming-Guang He; Adnan Tufail; Mong Li Lee; Wynne Hsu; Daniel Shu Wei Ting
Journal:  Curr Diab Rep       Date:  2019-07-31       Impact factor: 4.810

2.  Siamese neural networks for continuous disease severity evaluation and change detection in medical imaging.

Authors:  Matthew D Li; Ken Chang; Ben Bearce; Connie Y Chang; Ambrose J Huang; J Peter Campbell; James M Brown; Praveer Singh; Katharina V Hoebel; Deniz Erdoğmuş; Stratis Ioannidis; William E Palmer; Michael F Chiang; Jayashree Kalpathy-Cramer
Journal:  NPJ Digit Med       Date:  2020-03-26

Review 3.  [Potential of methods of artificial intelligence for quality assurance].

Authors:  Philipp Berens; Sebastian M Waldstein; Murat Seckin Ayhan; Louis Kümmerle; Hansjürgen Agostini; Andreas Stahl; Focke Ziemssen
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

4.  An Ophthalmologist's Guide to Deciphering Studies in Artificial Intelligence.

Authors:  Daniel S W Ting; Aaron Y Lee; Tien Y Wong
Journal:  Ophthalmology       Date:  2019-09-21       Impact factor: 12.079

5.  Identifying Diabetic Macular Edema and Other Retinal Diseases by Optical Coherence Tomography Image and Multiscale Deep Learning.

Authors:  Quan Zhang; Zhiang Liu; Jiaxu Li; Guohua Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-04       Impact factor: 3.168

6.  Assessing the Trustworthiness of Saliency Maps for Localizing Abnormalities in Medical Imaging.

Authors:  Nishanth Arun; Nathan Gaw; Praveer Singh; Ken Chang; Mehak Aggarwal; Bryan Chen; Katharina Hoebel; Sharut Gupta; Jay Patel; Mishka Gidwani; Julius Adebayo; Matthew D Li; Jayashree Kalpathy-Cramer
Journal:  Radiol Artif Intell       Date:  2021-10-06

7.  Artificial Intelligence for Refractive Surgery Screening: Finding the Balance Between Myopia and Hype-ropia.

Authors:  Travis K Redd; J Peter Campbell; Michael F Chiang
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

8.  The Potential and the Imperative: the Gap in AI-Related Clinical Competencies and the Need to Close It.

Authors:  Kim V Garvey; Kelly Jean Thomas Craig; Regina G Russell; Laurie Novak; Don Moore; Anita M Preininger; Gretchen P Jackson; Bonnie M Miller
Journal:  Med Sci Educ       Date:  2021-09-09

9.  Evaluation of Explainable Deep Learning Methods for Ophthalmic Diagnosis.

Authors:  Amitojdeep Singh; Janarthanam Jothi Balaji; Mohammed Abdul Rasheed; Varadharajan Jayakumar; Rajiv Raman; Vasudevan Lakshminarayanan
Journal:  Clin Ophthalmol       Date:  2021-06-18

Review 10.  Interpretation and visualization techniques for deep learning models in medical imaging.

Authors:  Daniel T Huff; Amy J Weisman; Robert Jeraj
Journal:  Phys Med Biol       Date:  2021-02-02       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.